5 Stocks Driving The Health Services Industry Higher

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 90 points (0.6%) at 15,153 as of Tuesday, Sept. 10, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,842 issues advancing vs. 1,092 declining with 95 unchanged.

The Health Services industry currently sits up 0.3% versus the S&P 500, which is up 0.5%. Top gainers within the industry include DENTSPLY International ( XRAY), up 2.4%, Universal Health Services ( UHS), up 1.9%, HCA Holdings ( HCA), up 1.6%, Grifols ( GRFS), up 1.5% and ResMed ( RMD), up 1.3%.

TheStreet would like to highlight 5 stocks pushing the industry higher today:

5. Varian Medical Systems ( VAR) is one of the companies pushing the Health Services industry higher today. As of noon trading, Varian Medical Systems is up $1.15 (1.6%) to $73.60 on average volume. Thus far, 527,779 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 713,600 shares. The stock has ranged in price between $72.63-$73.74 after having opened the day at $72.70 as compared to the previous trading day's close of $72.45.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.7 billion and is part of the health care sector. Shares are up 2.3% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Varian Medical Systems Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Laboratory Corporation of America Holdings ( LH) is up $1.30 (1.3%) to $99.80 on average volume. Thus far, 351,650 shares of Laboratory Corporation of America Holdings exchanged hands as compared to its average daily volume of 662,300 shares. The stock has ranged in price between $99.04-$99.91 after having opened the day at $99.05 as compared to the previous trading day's close of $98.50.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. Laboratory Corporation of America Holdings has a market cap of $8.8 billion and is part of the health care sector. Shares are up 13.7% year to date as of the close of trading on Monday. Currently there are 2 analysts that rate Laboratory Corporation of America Holdings a buy, 2 analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates Laboratory Corporation of America Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in stock price during the past year, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Laboratory Corporation of America Holdings Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Humana ( HUM) is up $1.29 (1.4%) to $96.73 on average volume. Thus far, 434,687 shares of Humana exchanged hands as compared to its average daily volume of 1.1 million shares. The stock has ranged in price between $95.44-$96.85 after having opened the day at $95.93 as compared to the previous trading day's close of $95.44.

Humana Inc., a health care company, offers a range of insurance products, and health and wellness services that incorporate an integrated approach to lifelong well-being. The company operates in three segments: Retail, Employer Group, and Healthcare Services. Humana has a market cap of $15.0 billion and is part of the health care sector. Shares are up 39.4% year to date as of the close of trading on Monday. Currently there are 11 analysts that rate Humana a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Humana as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, attractive valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Humana Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Cigna ( CI) is up $0.68 (0.8%) to $81.35 on light volume. Thus far, 446,074 shares of Cigna exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $80.83-$81.75 after having opened the day at $80.93 as compared to the previous trading day's close of $80.67.

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $22.9 billion and is part of the health care sector. Shares are up 51.2% year to date as of the close of trading on Monday. Currently there are 8 analysts that rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Cigna as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Cigna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Covidien ( COV) is up $0.38 (0.6%) to $61.52 on average volume. Thus far, 1.3 million shares of Covidien exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $60.99-$61.68 after having opened the day at $61.38 as compared to the previous trading day's close of $61.14.

Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide. Covidien has a market cap of $27.9 billion and is part of the health care sector. Shares are up 5.2% year to date as of the close of trading on Monday. Currently there are 13 analysts that rate Covidien a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Covidien as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures, notable return on equity and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Covidien Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists